Table 2.
PSS scores—primary outcome (primary outcome for the 3 groups at all 3 time points).
| Baseline | Week 6 | Week 12 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Active comparators (n = 1,177) |
Placebo comparators (n = 1,161) |
Yoga practitioners (n = 4,554) |
P -Value |
Active comparators (n = 218) |
Placebo comparators (n = 228) |
Yoga practitioners (n = 2,745) |
P -Value |
Active comparators (n = 163) |
Placebo comparators (n = 171) |
Yoga practitioners (n = 2,366) |
P -Value | |
| PSS score, median (IQR) | (n = 1,176)a | (n = 1,160) | (n = 4,552) | <0.0001 | (n = 207) | (n = 222) | (n = 2,658) | <0.0001 | (n = 146) | (n = 157) | (n = 2,108) | <0.0001 |
| 16 (12, 21) | 16 (12, 21) | 11 (7, 15) | 12 (8, 17) | 14 (9, 18) | 9 (6, 13) | 11.5 (8, 16) | 13 (8, 17) | 9 (5, 13) | ||||
a
(n = X) represents the number of patients with PSS scores in the specific group at the specific time point.